Form 4 for ERAS Erasca, Inc.
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-28 · accession 0001209191-23-021458 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-28 | 2023-03-28 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.84 | +100.0K | 18.30M | +0.5% | +$284.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-28 | P | A | 100,000 | $2.84 | 18,296,216 | I By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 | — | — | (F1) The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005. |